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ABSTRACT 
Background: Pediatric patients newly diagnosed with ALL undergo a LP to determine if 
they have disease in their CNS. A LP can be traumatic, meaning leukemic cells are inadver-
tently introduced into the CNS, resulting in worse outcomes for patients. Previous studies 
have shown risk factors for a TLP include provider level, level of sedation, platelet count, 
age, and race. 
Purpose: The purpose of this study was to determine risk factors for a TLP in our patient 
population in the current treatment era. The study secondarily aimed to determine if a TLP 
was associated with relapse of ALL in the CNS. 
Methods: This was a single-center, retrospective chart review. Patients were included if they
were pediatric patients (18 years or younger), newly diagnosed with ALL, and underwent a 
diagnostic LP within 72 hours of diagnosis. Age, race, sex, risk stratification of ALL, treat-
ment protocol, serum WBC count, platelet count, number of platelet transfusions, CSF WBC 
and RBC counts, presence of blasts in CSF, CNS status, BMI, level of sedation, location of pro-
cedure, and level of performing practitioner were recorded. 
Results: The study showed that location of LP (p=0.0380) in an OR and sedation under gen-
eral anesthesia (p=0.0099) were significantly associated with a decreased risk of TLP. The 
study also showed that a TLP is associated with an increased risk of CNS relapse in pediatric
patients with ALL (p=0.0381).
Conclusion: LPs should be performed in an OR under general anesthesia. While our study 
did not show that level of provider was significantly associated with TLPs, it is recom-
mended that the highest level of provider available perform the diagnostic LP. 
INTRODUCTION
Acute lymphoblastic leukemia (ALL) is the most common of all childhood cancers with ap-
proximately 4900 children being diagnosed each year.1 Peak incidence is estimated to be be-
tween 2 and 5 years of age, and it is more common among white children. Despite a cure 
rate of approximately 0% in the 1950s, the event free survival (EFS) rate is 75-80% overall 
and greater than 90% in some subtypes presently due to advancements in chemotherapy.1
ALL is diagnosed by performing a bone marrow biopsy and aspiration.  A normal bone mar-
row should contain less than 5% immature white blood cells (WBC), also known as blasts. 
However, in patients with ALL, greater than 20% of the marrow contains blasts. A lumbar 
puncture (LP) is performed to determine if a patient has blasts in his/her central nervous 
system (CNS). If blasts are present, the patient is said to have CNS disease. CNS disease can 
be classified as status 1, 2, or 3 depending on the presence of blasts in the CNS and the num-
ber of mature WBCs.2 
Historically, CNS disease has been associated with an increased rate of mortality.1,2,3 At base-
line, it is estimated 3-8 percent of patients have CNS disease. Further, it is estimated that 30 
to 40 percent of patients who relapse will relapse in the CNS.3 Consequently, performing an 
initial LP at diagnosis is imperative for proper treatment of a patient’s ALL. Furthermore, 
LPs are given frequently throughout treatment to reassess CNS status and provide intrathe-
cal (IT) chemotherapy. The concern with frequent LPs is that a traumatic LP (TLP) can occur.
A TLP occurs with blood is unintentionally introduced into the subarachnoid space during 
the procedure.  A TLP could therefore introduce blasts into the CNS, inadvertently giving a 
patient CNS disease and putting them at a higher risk of mortality.3
The purpose of this study is to report the association of modifiable and non-modifiable risk 
factors with the frequency of TLP at University of North Carolina Children’s Hospital in chil-
dren with ALL. A secondary analysis is aimed to show if there exists association between 
TLPs and relapse of disease. 
RATIONALE
The basis for this study primarily comes from 2 previous studies. In 2000, the association of 
TLP with adverse outcomes in childhood ALL was established in a landmark study by Gajjar 
et al.  The study was a retrospective chart review of 546 newly diagnosed ALL patients at 
Saint Jude’s Children’s Research Hospital.  The study found that patients with a TLP had sig-
nificantly worse 5-year EFS than patients without a TLP (p=0.026). The authors concluded 
patients with a TLP needed more aggressive IT therapy, and that a dose of IT chemotherapy 
should be administered with the diagnostic LP to prevent multiple LPs at treatment begin-
ning.4 These recommendations exist in current practice. 
A second study performed by Howard et al. in 2002 analyzed risk factors for a TLP. The 
study divided risk factors for a TLP into modifiable and non-modifiable risk factors. Modifi-
able risk factors for a TLP were determined to be treatment era (if LPs were performed un-
der conscious sedation or general anesthesia), if the TLP was performed with a platelet 
count of less than or equal to 100,000, if LPs were performed within 15 or fewer days of one
another, and the level of experience of the practitioner. Non-modifiable risk factors included 
black race, age less than 1 year, a bloody LP within the last 2 weeks, or a previous LP when 
the platelet count was less than or equal to 50,000.5  This study will differ from the 2002 
study because all patients will be in a new treatment era where it is standard of care to un-
dergo LPs under general anesthesia in an operating room. Current practice has also changed
from practice in the aforementioned studies as patients now receive their first dose of IT cy-
tarabine with their diagnostic LP.
METHODS
Patients and Procedures
This study is a single-center, retrospective chart review of two hundred nineteen pediatric 
patients newly diagnosed with ALL from June 2000 to June 2013. Each patient received a 
single diagnostic LP for diagnosis of CNS disease and first dose of IT cytarabine. Patients 
were then treated based on their CNS classification and study protocols.  It was standard 
protocol at the time that LPs be performed under general anesthesia unless unwarranted by 
patient’s clinical condition (those patients were to at least receive conscious sedation). 
Serum WBC, platelet count, weight, height, and calculated BMI were collected prior to proce-
dure. It was documented whether or not the patient received a platelet transfusion before 
procedure. Each LP was sent for a cell count, differential, and hematopathologic review. Pro-
cedure notes were then reviewed for level of sedation used, level of provider performing the
procedure, and any notes surrounding the procedure that indicated complications. Number 
of attempts and length and gauge of needle were recorded when possible.  Results of the LP 
were assessed to determine if the tap was traumatic. The institutional review board ap-
proved this study. 
Inclusion and Exclusion Criteria
Patients were included if they were less than or equal to 18 years of age, newly diagnosed 
with ALL, and received a diagnostic LP within 72 hours of diagnosis. Patients were excluded 
from review if the LP was performed at another institution and that data was not available. 
Definitions
A TLP was defined as those in which the cerebral spinal fluid (CSF) contained at least 10 
RBCs per microliter.  Bloody LPs, a subset of TLPs, contained at least 500 RBCs per micro-
liter. These definitions were consistent with the Howard et al study. CNS status was defined 
by the Children’s Oncology Group (COG).
Variables and Statistical Analysis 
Age, race, sex, risk stratification of ALL, treatment protocol, serum WBC count, platelet 
count, number of platelet transfusions, CSF WBC and RBC counts, presence of blasts in CSF, 
CNS status, BMI, level of sedation, location of procedure, and level of performing practi-
tioner were recorded. Level of sedation was determined based on medications received as 
follows: sevoflurane and propofol for general anesthesia; ketamine, midazolam, or fentanyl 
for conscious sedation, and lidocaine for local anesthesia. Locations included the operating 
room, pediatric ICU, outpatient clinic, inpatient floor, or in fluoroscopy if the patient’s habi-
tus required. Practitioners were recorded as attending, fellow, nurse practitioner (NP), or 
radiology resident (if in fluoroscopy). 
Descriptive statistics (mean) were determined for all variables. The association of predictor 
variables with TLP were determined using the Fisher’s exact test or the Wilcoxon Rank Sum 
test for categorical data or continuous variables, respectively. A logistic regression was per-
formed to determine the relationship between TLP and relapse rate. 
RESULTS
Two hundred nineteen patients were included in the analysis. The majority of patients were 
female (58.90%), Caucasian (64.40%), and older than 1 (95.90%). The mean WBC was 
60.83 x 109 per liter, and the mean platelet count was 96.83 x 109 per liter. Most patients un-
derwent general anesthesia (91.30%) in an OR (91.20%) and had their LP performed by an 
attending (75.50%). Due to variances in operating systems during the study period and re-
porting, CSF WBC and RBC and BMI were not reported. The baseline characteristics can be 
seen in Table 1. CNS data and LP data can be seen in Table 2. Thirty seven patients had a TLP
(17.0%) and twenty patients were CNS positive (9.1%). Most LPs occurred successfully on 
the first try (78.0%). Of the 219 patients, 15.1% had a relapse of their ALL, and 8 percent of 
patients relapsed in the CNS.  
Of the baseline characteristics, only level of sedation and location of LP were found to be sig-
nificantly associated with a TLP (p=0.0099 and p=0.0380, respectively). There were no dif-
ferences in rate of TLP with regards to age, level of provider, race, platelet count, number of 
platelet transfusions, or serum WBC. These results can be seen in Table 3. 
Finally, through logistic regression it was shown that a TLP is associated with a significant 
increase in CNS relapse (p=0.0381). 
Table 1. Baseline characteristics
Characteristic Frequency (n=219) 
Male
Female
41.10% 
58.90%
Caucasian
African American
Other
64.40%
14.60%
21%
Mean WBC count 
(x109/L)
60.83
Mean Platelet Count 
(x109/L)
96.43
Age <1
Age >1
4.10%
95.90%
General Anesthesia
Conscious Sedation
91.30%
8.70%
Platelet transfusion 47%
Table 2. CNS and LP Data 
Characteristic/Out
come
Frequency (n=219)
CNS Positive 9.1%
Number of Attempts
   1
   2
   3+
78.0%
18.6%
3.4%
TLP 17.0%
Relapse
   CNS
   ALL
   Other
8.0%
15.1%
11.4%
Table 3. Association of risk factors with a TLP
Risk Factor Association (p value)
Level of provider p=0.5633
Age p=0.4892
Race p=0.8964
Platelet count p=0.4726
WBC p=0.6487
Location of LP p=0.0380
Level of sedation p=0.0099
Platelet transfusion p=0.1476
DISCUSSION
Results and Conclusions
The purpose of this study was to assess risk factors for TLPs in pediatric patients with 
newly diagnosed ALL. There was a secondary outcome of determining whether or not a TLP 
was associated with CNS relapse. This study differed from previous studies because all pa-
tients had LPs performed in the new treatment era, meaning under general anesthesia in an 
OR. In this single-center, retrospective chart review, it was shown that performing diagnostic
LPs under general anesthesia and in an OR is significantly associated with a decreased risk 
of TLP. This was expected as this is current standard-of-care, and this finding is consistent 
with the Howard et al study. Unlike the Howard et al study, however, we did not find that 
higher level of provider, age less than 1, or a platelet count less than or equal to 50,000 were 
associated with a TLP. Reasons we did not find a difference could include a limited sample 
size compared to previous studies (219 versus 956 in Howard et al.). Furthermore, more 
LPs were performed by attendings in our study as compared to previous studies.  The aver-
age platelet count was also higher than expected and could explain not finding an associa-
tion.  
The CNS relapse rate of 8 percent is comparable to previous studies. The rate of TLP (17%), 
however, was lower than expected. As discussed previously, this could be due to high num-
bers of patients undergoing LPs in an OR under general anesthesia by an attending. Our 
study did show that a TLP is associated with an increased rate of relapse in the CNS, which 
is consistent with the Gajjar et al. study. This further supports the importance of taking mea-
sures to ensure diagnostic LPs are performed in a controlled setting under general anesthe-
sia with the highest-level practitioner available. 
Study Strengths and Limitations 
Study strengths and limitations exist primarily within the retrospective nature of the study. 
Because the study was retrospective, we were able to obtain patient data over an extended 
13-year time period. Further, all patients were analyzed in the most recent treatment era. 
Very few patients were excluded from the study, which improves the generalizability of the 
findings. However, also due to the retrospective design, not all data was present for each pa-
tient. There was also a limited sample size because the study was only conducted for Univer-
sity of North Carolina Children’s Hospital patients. Also because the study was single-center, 
all patients were treated under one hospital policy. Finally, the hospital changed systems 
during the study period, and thus some data was more difficult to collect and reported dif-
ferently. 
Obstacles
The primary obstacle in study completion was obtaining all patient data. Many of the patient
charts before the implementation of a central electronic system (WebCis) were paper charts.
Information was often stored in various places and at times handwriting could be difficult to
interpret. Furthermore, immediately following project completion, evaluators moved to var-
ious institutions. The completion of the data analysis was delayed for this reason.  
Future Plans and Directions
A manuscript is currently being written discussing our study results. Our study can add to 
the current literature validating current standard of practice. Currently, studies are ongoing 
to determine if patients with CNS2 disease should be treated as aggressively as patients 
with CNS3 disease. This applies to our study, as many patients with a TLP will then be diag-
nosed with CNS2 disease. Consequently, results from these studies could change how pa-
tients with a TLP are treated. 
SUMMARY
This study validates the current treatment standard that all patients should receive diagnos-
tic LPs in an OR under general anesthesia. While our study did not find that provider level 
and platelet count were significantly associated with TLPs, these findings have been docu-
mented in the literature5 and it is recommended that the highest practitioner available per-
form the LP and caution be exercised in children with low platelet counts.  
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